BRPI0307673A2 - métodos de tratar doença vascular. - Google Patents

métodos de tratar doença vascular.

Info

Publication number
BRPI0307673A2
BRPI0307673A2 BRPI0307673A BR0307673A BRPI0307673A2 BR PI0307673 A2 BRPI0307673 A2 BR PI0307673A2 BR PI0307673 A BRPI0307673 A BR PI0307673A BR 0307673 A BR0307673 A BR 0307673A BR PI0307673 A2 BRPI0307673 A2 BR PI0307673A2
Authority
BR
Brazil
Prior art keywords
methods
vascular disease
treating vascular
treating
disease
Prior art date
Application number
BRPI0307673A
Other languages
English (en)
Inventor
Augustine M K Choi
Brian Zuckerbraun
Fritz H Bach
Leo E Otterbein
Original Assignee
Beth Israel Hospital
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital, Univ Pittsburgh filed Critical Beth Israel Hospital
Publication of BRPI0307673A2 publication Critical patent/BRPI0307673A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
BRPI0307673A 2002-02-13 2003-02-13 métodos de tratar doença vascular. BRPI0307673A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35671802P 2002-02-13 2002-02-13
PCT/US2003/004665 WO2003072024A2 (en) 2002-02-13 2003-02-13 Methods of treating vascular disease

Publications (1)

Publication Number Publication Date
BRPI0307673A2 true BRPI0307673A2 (pt) 2016-11-08

Family

ID=27765943

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0307673A BRPI0307673A2 (pt) 2002-02-13 2003-02-13 métodos de tratar doença vascular.

Country Status (15)

Country Link
US (2) US7364757B2 (pt)
EP (1) EP1480658B1 (pt)
JP (1) JP2005525848A (pt)
KR (1) KR20040096571A (pt)
CN (1) CN100393323C (pt)
AU (1) AU2003211102B2 (pt)
BR (1) BRPI0307673A2 (pt)
CA (1) CA2475963A1 (pt)
CO (1) CO5611156A2 (pt)
EA (1) EA200401070A1 (pt)
MX (1) MXPA04007896A (pt)
NO (1) NO20034590L (pt)
SG (1) SG148850A1 (pt)
UA (1) UA86344C2 (pt)
WO (1) WO2003072024A2 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
KR20040032115A (ko) * 2001-06-21 2004-04-14 베쓰 이스라엘 디코니스 메디칼 센터 인크 조직 및 장기 이식 결과의 개선 및 아폽토시스의 억제에사용되는 일산화탄소
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP1476168A2 (en) 2002-02-04 2004-11-17 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
EA200401070A1 (ru) * 2002-02-13 2005-02-24 Бет Изрейэл Диконисс Медикал Сентер, Инк. Способы лечения сосудистых заболеваний
CA2482260A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
UA86570C2 (ru) 2002-04-15 2009-05-12 Юниверсити Оф Питтсбург Оф Дзе Коммонвелз Систем Оф Хайер Эдьюкейшн Способ лечения некротизирующего энтероколита
US7687079B2 (en) 2002-04-15 2010-03-30 University of Pittsburgh of the Commonwealth System of Higher Education Yale University Methods of treating ileus
ES2372273T3 (es) 2002-05-17 2012-01-17 Yale University Métodos de tratamiento de la hepatitis.
UA87438C2 (ru) * 2002-06-05 2009-07-27 Йельский Университет Способы лечения или профилактики рака, способ проведения хирургической операции по удалению рака и применения монооксида углерода
MXPA04012863A (es) * 2002-06-21 2005-03-31 Univ Pittsburgh Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme.
EA200500782A1 (ru) * 2002-11-07 2005-10-27 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Лечение геморрагического шока
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
US20040236279A1 (en) * 2003-05-22 2004-11-25 Atrium Medical Corp. Gaseous therapeutic agent delivery
EP2363022A3 (en) 2003-10-22 2011-12-21 Fred Hutchinson Cancer Research Center Use of oxygen antagonists for the therapeutic treatment of mammals
WO2006024491A1 (en) * 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
US8893717B2 (en) 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US20080160064A1 (en) * 2006-12-22 2008-07-03 Capelli Christopher C Devices and methods for inhibiting fibrosis
JP5639645B2 (ja) 2009-05-27 2014-12-10 イノ セラピューティクス エルエルシー 指標付弁と襟部を有する加圧容器組立体を係合するため、かつ薬物送達を調整するための装置と流体連通したプランジャ組立体により直線的に作動させるための装置および方法
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
HUP1000243A2 (en) 2010-05-06 2012-01-30 Avidin Kft 8-hidroxy-quinoline derivatives
US8778413B2 (en) * 2010-05-14 2014-07-15 Ikaria, Inc. Dosing regimens and methods of treatment using carbon monoxide
EP2663193B1 (en) * 2011-01-14 2019-05-08 Children's Hospital Los Angeles Solution of carbon monoxide for treatment of disease, including sickle cell disease
EP2699242B1 (en) 2011-04-19 2017-11-01 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
WO2013022946A1 (en) 2011-08-09 2013-02-14 Beth Israel Deaconess Medical Center, Inc. Methods of treating dna damage
JP6245613B2 (ja) 2012-03-15 2017-12-13 マリンクロット ホスピタル プロダクツ アイピー リミテッド 高濃度の一酸化窒素の投与法
US20140272924A1 (en) * 2013-03-14 2014-09-18 Ganogen, Inc. Transplantation and growth of human fetal organs in non-human animal hosts
TW201618795A (zh) 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
JP6591203B2 (ja) * 2015-06-01 2019-10-16 キヤノンメディカルシステムズ株式会社 医用画像処理装置
CN113289074A (zh) * 2020-02-24 2021-08-24 张建强 一种新型的药物涂层支架及其制备方法
US20230398141A1 (en) * 2020-09-08 2023-12-14 The Brigham And Women's Hospital, Inc. Therapeutic carbon monoxide formulations

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) * 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
JPS5679957A (en) 1979-12-05 1981-06-30 Sogo Seibutsu Igaku Kenkyusho:Kk Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US4979939A (en) * 1984-05-14 1990-12-25 Surgical Systems & Instruments, Inc. Atherectomy system with a guide wire
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) * 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
US5674192A (en) 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5180366A (en) * 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) * 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
GB9124195D0 (en) * 1991-11-14 1992-01-08 Boc Group Plc Connection to a gas cylinder
US5293875A (en) * 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
DK0693924T4 (da) * 1993-02-22 2008-08-04 Abraxis Bioscience Inc Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil
WO1994022482A1 (en) 1993-03-26 1994-10-13 Biorelease Technologies, Inc. Compositions including heme-containing proteins and methods relating thereto
US5523092A (en) * 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5985307A (en) * 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US5763431A (en) * 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
US5588962A (en) * 1994-03-29 1996-12-31 Boston Scientific Corporation Drug treatment of diseased sites deep within the body
DE4421433C1 (de) * 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) * 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
JPH0898893A (ja) * 1994-09-29 1996-04-16 Terumo Corp 薬剤投与カテーテル
US5664563A (en) * 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) * 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
JP3019366U (ja) * 1995-06-13 1995-12-12 株式会社大東バルブ製作所 特定ガス用ボンベ
FR2735382B1 (fr) * 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
EP0835115B1 (en) * 1995-06-30 2004-05-06 ZymoGenetics, Inc. 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists
DE19535781C2 (de) * 1995-09-26 1999-11-11 Fraunhofer Ges Forschung Vorrichtung zur aktiven Strömungsunterstützung von Körperflüssigkeiten
JP2000510448A (ja) * 1996-04-05 2000-08-15 ザ ジェネラル ホスピタル コーポレーション 異常ヘモグロビン症の治療
US6069132A (en) * 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
ATE293458T1 (de) * 1996-08-23 2005-05-15 Algos Pharm Corp Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
ES2210585T3 (es) * 1996-08-27 2004-07-01 Messer Griesheim Gmbh Medicamento que contiene hidrogeno.
US6315995B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6316403B1 (en) * 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
ATE358492T1 (de) * 1996-09-27 2007-04-15 Univ Columbia Behandlung einer ischämischen störung und zur verbesserung des infarktergebnis
US6436365B2 (en) * 1997-09-23 2002-08-20 Schering Aktiengesellschaft Process for therapeutic treatment of proliferative diseases
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
BR9908811A (pt) 1998-03-16 2000-12-05 Celgene Corp Composto, composição farmacêutica e seu uso no tratamento de mamìferos
US6450989B2 (en) * 1998-04-27 2002-09-17 Artemis Medical, Inc. Dilating and support apparatus with disease inhibitors and methods for use
JP4023919B2 (ja) * 1998-07-21 2007-12-19 株式会社フクダ産業 肺機能検査装置
US6203991B1 (en) * 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US20050250688A1 (en) * 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
DE19932824A1 (de) * 1999-07-14 2001-03-08 Nordischer Maschinenbau Verfahren und Vorrichtung zum Ausrichten eines toten Fisches
JP2001082698A (ja) * 1999-09-16 2001-03-30 Teijin Ltd 医療用酸素ボンベ
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6508784B1 (en) * 2000-05-19 2003-01-21 Yan-Ho Shu Balloon catheter having adjustable centering capabilities and methods thereof
FR2812197B1 (fr) 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
US20040197271A1 (en) * 2001-03-20 2004-10-07 Kunka Robert Leonard Inhalation drug combinations
CN1507348A (zh) 2001-03-30 2004-06-23 ɣ����ҽҩ��˾ 用于治疗血管性、炎性和免疫疾病的一氧化碳生成性组合物
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP1395241B9 (en) * 2001-05-25 2005-06-15 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
KR20040032115A (ko) 2001-06-21 2004-04-14 베쓰 이스라엘 디코니스 메디칼 센터 인크 조직 및 장기 이식 결과의 개선 및 아폽토시스의 억제에사용되는 일산화탄소
EP1476168A2 (en) * 2002-02-04 2004-11-17 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
EA200401070A1 (ru) * 2002-02-13 2005-02-24 Бет Изрейэл Диконисс Медикал Сентер, Инк. Способы лечения сосудистых заболеваний
CA2482260A1 (en) * 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
DE10230165A1 (de) 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Verfahren und Vorrichtung zur Administration von Kohlenmonoxid

Also Published As

Publication number Publication date
CN100393323C (zh) 2008-06-11
US20080167609A1 (en) 2008-07-10
KR20040096571A (ko) 2004-11-16
CA2475963A1 (en) 2003-09-04
US7691416B2 (en) 2010-04-06
EA200401070A1 (ru) 2005-02-24
AU2003211102B2 (en) 2010-03-04
WO2003072024A3 (en) 2004-02-26
US20030219496A1 (en) 2003-11-27
EP1480658A4 (en) 2005-03-16
CN1646146A (zh) 2005-07-27
US7364757B2 (en) 2008-04-29
UA86344C2 (ru) 2009-04-27
JP2005525848A (ja) 2005-09-02
WO2003072024A2 (en) 2003-09-04
SG148850A1 (en) 2009-01-29
CO5611156A2 (es) 2006-02-28
EP1480658A2 (en) 2004-12-01
MXPA04007896A (es) 2005-06-17
NO20034590D0 (no) 2003-10-13
AU2003211102A1 (en) 2003-09-09
NO20034590L (no) 2003-12-12
EP1480658B1 (en) 2017-01-25

Similar Documents

Publication Publication Date Title
BRPI0307673A2 (pt) métodos de tratar doença vascular.
NO20053041D0 (no) Behandling av diabetes.
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
NO20052058D0 (no) Behandling av influensa.
SI1706112T1 (sl) Postopki za zdravljenje vnetne bolezni
NO20035156L (no) Fremgangsmåter for brønnbehandling
DE502004002801D1 (de) Bohrlochbehandlungsmittel, enthaltend ethercarbonsäuren
IS8050A (is) Æðaígræði
DE602004012562D1 (de) Strahlaufbereitungssystem
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
IS7825A (is) Meðferðarfræðileg meðhöndlun
DE60223576D1 (de) Hautbehandlungszusammensetzung
GB0320238D0 (en) Treatment of disease
SE0402458L (sv) Igensättningsmotverkande behandlingar
ATE389742T1 (de) Gewebebehandlungsmittel
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
DE60220220D1 (de) Blutbehandlungssystem
DE602004004262D1 (de) Ultraschallbehandlung von gewebematrices
PT102870A (pt) Metodo de tratamento de condensados
FR2837224B1 (fr) Bonde traitante
BR0312187B1 (pt) método para o tratamento de sementes
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
IS8477A (is) Beta-laktöm til að meðhöndla MTK sjúkdóma
ITVE20020040A1 (it) Procedimento di trattamento delle pelli. -
FR2852507B1 (fr) Prothese vasculaire

Legal Events

Date Code Title Description
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: ANULADA A EXIGENCIA 6.7 PUBLICADA NA RPI 1871 DE 14/11/2006 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]